Literature DB >> 19965656

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Cyril Fauriat1, Eric O Long, Hans-Gustaf Ljunggren, Yenan T Bryceson.   

Abstract

Natural killer (NK)-cell recognition of infected or neoplastic cells can induce cytotoxicity and cytokine secretion. So far, it has been difficult to assess the relative contribution of multiple NK-cell activation receptors to cytokine and chemokine production upon target cell recognition. Using Drosophila cells expressing ligands for the NK-cell receptors LFA-1, NKG2D, DNAM-1, 2B4, and CD16, we studied the minimal requirements for secretion by freshly isolated, human NK cells. Target cell stimulation induced secretion of predominately proinflammatory cytokines and chemokines. Release of chemokines MIP-1alpha, MIP-1beta, and RANTES was induced within 1 hour of stimulation, whereas release of TNF-alpha and IFN-gamma occurred later. Engagement of CD16, 2B4, or NKG2D sufficed for chemokine release, whereas induction of TNF-alpha and IFN-gamma required engagement of additional receptors. Remarkably, our results revealed that, upon target cell recognition, CD56(dim) NK cells were more prominent cytokine and chemokine producers than CD56(bright) NK cells. The present data demonstrate how specific target cell ligands dictate qualitative and temporal aspects of NK-cell cytokine and chemokine responses. Conceptually, the results point to CD56(dim) NK cells as an important source of cytokines and chemokines upon recognition of aberrant cells, producing graded responses depending on the multiplicity of activating receptors engaged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965656      PMCID: PMC2844017          DOI: 10.1182/blood-2009-08-238469

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

1.  Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets.

Authors:  Veronica D Gonzalez; Niklas K Björkström; Karl-Johan Malmberg; Markus Moll; Carlotta Kuylenstierna; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Johan K Sandberg
Journal:  J Immunol Methods       Date:  2007-12-04       Impact factor: 2.303

Review 2.  Functionally distinct NK-cell subsets: developmental origins and biological implications.

Authors:  James P Di Santo
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

Review 3.  Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues.

Authors:  Christian Münz
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

Review 4.  Line of attack: NK cell specificity and integration of signals.

Authors:  Yenan T Bryceson; Eric O Long
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

Review 5.  Functions of natural killer cells.

Authors:  Eric Vivier; Elena Tomasello; Myriam Baratin; Thierry Walzer; Sophie Ugolini
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 6.  Natural killer cells: diversity in search of a niche.

Authors:  James P Di Santo
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

7.  Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells.

Authors:  L R Grant; Z-J Yao; C M Hedrich; F Wang; A Moorthy; K Wilson; D Ranatunga; J H Bream
Journal:  Genes Immun       Date:  2008-04-10       Impact factor: 2.676

Review 8.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

9.  Application of CD27 as a marker for distinguishing human NK cell subsets.

Authors:  Anabel Silva; Daniel M Andrews; Andrew G Brooks; Mark J Smyth; Yoshihiro Hayakawa
Journal:  Int Immunol       Date:  2008-03-07       Impact factor: 4.823

10.  The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.

Authors:  Rossana Trotta; David Ciarlariello; Jessica Dal Col; Jeffrey Allard; Paolo Neviani; Ramasamy Santhanam; Hsiaoyin Mao; Brian Becknell; Jianhua Yu; Amy K Ferketich; Brittany Thomas; Aalok Modi; Bradley W Blaser; Danilo Perrotti; Michael A Caligiuri
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307

View more
  324 in total

1.  Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1.

Authors:  Ruipeng Wang; Jessica J Jaw; Nicole C Stutzman; Zhongcheng Zou; Peter D Sun
Journal:  J Leukoc Biol       Date:  2011-11-01       Impact factor: 4.962

2.  Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.

Authors:  Caroline Veuillen; Thérèse Aurran-Schleinitz; Rémy Castellano; Jérôme Rey; Françoise Mallet; Florence Orlanducci; Laurent Pouyet; Sylvaine Just-Landi; Diane Coso; Vadim Ivanov; Xavier Carcopino; Réda Bouabdallah; Yves Collette; Cyril Fauriat; Daniel Olive
Journal:  J Clin Immunol       Date:  2012-02-09       Impact factor: 8.317

3.  miR-155 regulates IFN-γ production in natural killer cells.

Authors:  Rossana Trotta; Li Chen; David Ciarlariello; Srirama Josyula; Charlene Mao; Stefan Costinean; Lianbo Yu; Jonathan P Butchar; Susheela Tridandapani; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

4.  Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.

Authors:  Andrea De Maria; Federica Bozzano; Claudia Cantoni; Lorenzo Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 5.  Immunological Consequences of JAK Inhibition: Friend or Foe?

Authors:  Donal P McLornan; Alesia A Khan; Claire N Harrison
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

6.  Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

Authors:  Sawa Ito; Catherine M Bollard; Mattias Carlsten; Jan Joseph Melenhorst; Angélique Biancotto; Ena Wang; Jinguo Chen; Yuri Kotliarov; Foo Cheung; Zhi Xie; Francesco Marincola; Kazushi Tanimoto; Minoo Battiwalla; Matthew J Olnes; Shira Perl; Paula Schum; Thomas E Hughes; Keyvan Keyvanfar; Nancy Hensel; Pawel Muranski; Neal S Young; A John Barrett
Journal:  Mol Ther       Date:  2014-04-01       Impact factor: 11.454

7.  Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy.

Authors:  Jianhong Zhang; Caroline E Dunk; Melissa Kwan; Rebecca L Jones; Lynda K Harris; Sarah Keating; Stephen J Lye
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

8.  A Daily Dose of 5 mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults.

Authors:  Clovis Paniz; Juliano Felix Bertinato; Maylla Rodrigues Lucena; Eduardo De Carli; Patrícia Mendonça da Silva Amorim; Guilherme Wataru Gomes; Cecília Zanin Palchetti; Maria Stella Figueiredo; Christine M Pfeiffer; Zia Fazili; Ralph Green; Elvira Maria Guerra-Shinohara
Journal:  J Nutr       Date:  2017-07-19       Impact factor: 4.798

9.  Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection.

Authors:  Thavamathi Annamalai; Zhongyan Lu; Kwonil Jung; Stephanie N Langel; Christopher K Tuggle; Jack C M Dekkers; Emily H Waide; Sukumar Kandasamy; Linda J Saif
Journal:  Virus Res       Date:  2019-05-02       Impact factor: 3.303

10.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.